Characteristics | All (n= 65) | Pso (n= 38) | PsA (n= 27) | P-value |
---|---|---|---|---|
Age, yr | 53 (41 to 61) | 54 (41 to 65) | 52 (41 to 59) | 0.526 |
Males, n (%) | 35 (54) | 21 (55) | 14 (52) | 0.806 |
Psoriasis disease duration, yr | 20 (9 to 32) | 20 (8 to 35) | 20 (10 to 31) | 0.931 |
Body surface area score, mean (SD) | 9.2 (16) | 8.1 (13.7) | 10.8 (19.0) | 0.827 |
PASI score, mean (SD) | 7.8 (9.3) | 7.3 (7.9) | 8.7 (11.2) | 0.967 |
Psoriatic arthritis, n (%) | 27 (41) | – | – | – |
Psoriatic arthritis disease duration, yr | – | – | 10 (4 to 15.5) | – |
Tender joint count (0 to 68), mean (SD) | – | – | 8.9 (10.8) | – |
Swollen joint count (0 to 66), mean (SD) | – | – | 5.4 (9.0) | – |
ASAS inflammatory back pain criteria met, n (%) | – | – | 4 (17) | – |
Calin inflammatory back pain criteria met, n (%) | – | – | 5 (21) | – |
Enthesitis score (0 to 6), mean (SD) | – | – | 1.0 (1.5) | – |
Dactylitis count (0 to 20), mean (SD) | – | – | 1.4 (3.8) | – |
Sacroiliac disease diagnosed by CT, n (%) | – | – | 12 (44) | – |
DMARD therapy, n (%) | 6 (9) | 2 (5) | 4 (15) | 0.224 |
Biologic therapy, n (%) | 25 (39) | 10 (26) | 15 (56) | 0.022 |
DMARD and biologic therapy, n (%) | 4 (6) | 2 (5) | 2 (7) | 1.000 |
NSAID therapy, n (%) | 15 (23) | 3 (8) | 12 (44) | 0.001 |
Phototherapy, n (%) | 3 (5) | 1 (3) | 2 (7) | 0.565 |
Topical steroid therapy, n (%) | 24 (37) | 14 (37) | 10 (37) | 1.000 |
Systemic steroid therapy, n (%) | 1 (2) | 0 (0) | 1 (4) | 0.415 |
Diabetes mellitus, n (%) | 7 (11) | 4 (11) | 3 (11) | 1.000 |
Hypertension, n (%) | 21 (32) | 13 (34) | 8 (30) | 0.791 |
Dyslipidemia, n (%) | 44 (68) | 29 (76) | 15 (56) | 0.108 |
Current tobacco use, n (%) | 6 (9) | 3 (8) | 3 (11) | 1.000 |
Former tobacco use, n (%) | 18 (28) | 12 (32) | 6 (22) | 0.684 |
Pack-years tobacco use | 0 (0 to 4.5) | 0 (0 to 5) | 0 (0 to 0.8) | 0.590 |
Diabetes mellitus therapy, n (%) | 4 (6) | 2 (5) | 2 (7) | 1.000 |
Antihypertensive therapy, n (%) | 12 (19) | 7 (18) | 5 (19) | 1.000 |
Hyperlipidemia therapy, n (%) | 24 (37) | 15 (39) | 9 (33) | 0.795 |
Body mass index, kg/m 2 | 29 (25.9 to 32.3) | 29 (24.9 to 32.4) | 29 (26.7 to 32) | 0.572 |
Systolic blood pressure, mmHg | 125 (116 to 135) | 129 (120 to 135) | 122 (115 to 133) | 0.266 |
Diastolic blood pressure, mmHg | 72 (65 to 78) | 71 (66 to 78) | 74 (63 to 79) | 0.719 |
Fasting blood glucose, mg/dl | 94 (89 to 104) | 94 (89 to 104) | 94 (89 to 107) | 0.895 |
Total cholesterol, mg/dl | 184 (158 to 203) | 185 (158 to 207) | 172 (157 to 201) | 0.910 |
Triglycerides, mg/dl | 108 (84 to 137) | 109 (84 to 149) | 101 (81 to 131) | 0.604 |
High-density lipoprotein cholesterol, mg/dl | 52 (42 to 63) | 52 (42 to 69) | 51 (47 to 59) | 0.947 |
Low-density lipoprotein cholesterol, mg/dl | 96 (80 to 125) | 95 (80 to 125) | 98 (78 to 125) | 0.851 |
Erythrocyte sedimentation rate, mm/hr | 8 (5 to 13) | 8 (4 to 10) | 12 (5 to 18) | 0.097 |
High-sensitivity C-reactive protein, g/dl | 1.7 (0.7 to 4.2) | 1.2 (0.7 to 3.1) | 3.0 (0.8 to 8) | 0.221 |